The exact cause of mixed connective tissue disease is unknown.

House then believes that the nun might have mixed connective tissue disease.

Examples of overlap syndromes include mixed connective tissue disease and scleromyositis.

It is sometimes associated with scleroderma and mixed connective tissue disease, auto-immune disorders.

Antibodies towards snRNP70 are associated with mixed connective tissue disease.

Anti-snRNP70 antibodies can be elevated in mixed connective tissue disease.

Patients can have symptoms and signs of lupus and scleroderma, called mixed connective tissue disease.

In addition to SLE, these antibodies are highly associated with mixed connective tissue disease.

But they can also suggest the presence of other autoimmune diseases, such as polymyositis, scleroderma, Sjögren's syndrome, mixed connective tissue disease, or rheumatoid arthritis.

Syndrome with symptoms of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon (mixed connective tissue disease)

Anti-RNP antibodies are autoantibodies associated with mixed connective tissue disease and are also detected in nearly 40% of Lupus erythematosus patients.

HnRNPA2B1 is an autoantigen in autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus and mixed connective tissue disease.

Other differential diagnostic considerations include interstitial lung disease related to mixed connective tissue disease, advanced sarcoidosis, chronic hypersensitivity pneumonitis, pulmonary Langerhans cell histiocytosis and radiation-induced fibrosis.

In medicine, mixed connective tissue disease (also known as Sharp's syndrome), commonly abbreviated as MCTD, is an autoimmune disease, in which the body's defense system attacks itself.

Connective Tissue Disease MCTD None Mixed connective tissue disease (MTCD) is a rare connective tissue disorder.

Our finding that only one in 10 asymptomatic patients with know connective tissue disease had a manometric abnormality is at variance with previous studies in patients with scleroderma and mixed connective tissue disease.

ENA 4 is a grouping of antibodies often used to screen for mixed connective tissue disease (MCTD), Sjögren's syndrome and systemic lupus erythematosus and commonly is composed of four tests:

An autoimmune basis has been suggested as PHT can be associated with rheumatological conditions including systemic lupus, scleroderma, and its CREST variant, mixed connective tissue disease, primary Sjogren's disease, and rheumatoid arthritis.

The fund would pay $200,000 to $2 million to women with any of eight diseases: systemic lupus, scleroderma, mixed connective tissue disease, polymyositis, dermatomyositis, primary Sjogren's disease, atypical neurological disease and atypical connective tissue disease/atypical rheumatic syndrome.

Other rheumatological disorders that can cause the features typical for RS3PE include late onset (seronegative) rheumatoid arthritis, acute sarcoidosis, ankylosing spondylitis and other spondyloarthropathies such as psoriatic arthropathy, mixed connective tissue disease, chondrocalcinosis and arthropathy due to amyloidosis.

Some disorders, such as SLE may be more likely if several autoantibodies are present, while others, such as MCTD (mixed connective tissue disease) may be more likely if a single autoantibody, RNP - ribonucleic protein is the only one present.